neocryptolepine and Stomach-Neoplasms

neocryptolepine has been researched along with Stomach-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for neocryptolepine and Stomach-Neoplasms

Article	Year
CFNC, a neocryptolepine derivative, inhibited the growth of gastric cancer AGS cells by inhibiting PI3K/AKT signaling pathway. European journal of pharmacology, 2023, Jan-05, Volume: 938 Topics: Antineoplastic Agents; Apoptosis; Biological Products; Cell Line, Tumor; Cell Proliferation; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Stomach Neoplasms; TOR Serine-Threonine Kinases	2023

Article

Year

CFNC, a neocryptolepine derivative, inhibited the growth of gastric cancer AGS cells by inhibiting PI3K/AKT signaling pathway.

European journal of pharmacology, 2023, Jan-05, Volume: 938

Topics: Antineoplastic Agents; Apoptosis; Biological Products; Cell Line, Tumor; Cell Proliferation; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Stomach Neoplasms; TOR Serine-Threonine Kinases

2023